Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Kala Pharmaceuticals, Inc. Initial Public Offering

Davis Polk advised the representatives of the several underwriters in connection with the $103.5 million initial public offering of common stock of Kala Pharmaceuticals, Inc. The…

PetSmart $2 Billion Notes Offering

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by PetSmart, Inc. of $1.35 billion of its 5.875% senior first-lien…

Editas Medicine, Inc. $90 Million Follow-On Offering

Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $90 million follow-on offering of 4,000,000 shares of common stock…

Ensco plc $650 Million Exchange Offers

Davis Polk advised the lead dealer managers, in connection with the Rule 144A/Regulation S exchange offers by Ensco plc pursuant to which it issued $332 million aggregate principal amount…
Back to top